Evidence map›Paper›PMID 38022384›Full record

ArticleBioImpacts : BI2023

Comparison the therapeutic effects of bone marrow CD144

Nahideh Nazdikbin Yamchi, Farhad Amjadi, Rahim Beheshti, Mehdi Hassanpour, Reza Shirazi, Amin Tamadon, Reza Rahbarghazi, Mahdi Mahdipour

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BioImpacts : BI, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 81% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Nahideh Nazdikbin YamchiStem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.ORCID https://orcid.org/0000-0003-1190-1309
Farhad AmjadiStem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Rahim BeheshtiFaculty of Veterinary Medicine, Shabestar Islamic Azad University, Shabestar, Iran.
Mehdi HassanpourStem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Reza ShiraziDepartment of Anatomy, School of Medical Sciences, Medicine & Health, UNSW Sydney, Sydney, Australia.
Amin TamadonPercia Vista R&D Co. Shiraz, Iran.ORCID https://orcid.org/0000-0002-0222-3035
Reza RahbarghaziDrug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.ORCID https://orcid.org/0000-0003-3864-9166
Mahdi MahdipourStem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.ORCID https://orcid.org/0000-0002-2729-4593
Tabriz University of Medical Sciences · IRIslamic Azad University Shabestar · IRUNSW Sydney · AUWest Kazakhstan Marat Ospanov State Medical University · KZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Premature ovarian insufficiency (POI) is a challenging issue in terms of reproduction biology. In this study, therapeutic properties of bone marrow CD146 Methods: POI rats were classified into control POI, POI + CD146 Results: Data indicated that injection of POI + CD146 Conclusion: The transplantation of bone marrow CD146

Indexed as

AngiogenesisBone marrowCD144 endothelial CellsCD146 mesenchymal Stem CellsFibrosisPremature ovarian insufficiency

Identifiers

PMID38022384
PMCPMC10676523
OpenAlexW4385881127

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.